Global Anti-inflammatory Therapeutics Market Insights, Forecast to 2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Anti-inflammatory Biologics
  • 1.4.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • 1.4.4 Corticosteroids
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Arthritis
  • 1.5.3 Respiratory Diseases
  • 1.5.4 Dermatology
  • 1.5.5 Gastroenterology
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Anti-inflammatory Therapeutics Market Perspective (2015-2026)
• 2.2 Anti-inflammatory Therapeutics Growth Trends by Regions
  • 2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Anti-inflammatory Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Anti-inflammatory Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Anti-inflammatory Therapeutics Players by Market Size
  • 3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio
  • 3.2.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2019
• 3.3 Anti-inflammatory Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Anti-inflammatory Therapeutics Product Solution and Service
• 3.5 Date of Enter into Anti-inflammatory Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2021-2026)

5 Anti-inflammatory Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Anti-inflammatory Therapeutics Market Size (2015-2020)
• 6.2 Anti-inflammatory Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Anti-inflammatory Therapeutics Market Size (2015-2020)
• 7.2 Anti-inflammatory Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Anti-inflammatory Therapeutics Market Size (2015-2020)
• 8.2 Anti-inflammatory Therapeutics Key Players in China (2019-2020)
• 8.3 China Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 8.4 China Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Anti-inflammatory Therapeutics Market Size (2015-2020)
• 9.2 Anti-inflammatory Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Anti-inflammatory Therapeutics Market Size (2015-2020)
• 10.2 Anti-inflammatory Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Anti-inflammatory Therapeutics Market Size (2015-2020)
• 11.2 Anti-inflammatory Therapeutics Key Players in India (2019-2020)
• 11.3 India Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 11.4 India Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Anti-inflammatory Therapeutics Market Size (2015-2020)
• 12.2 Anti-inflammatory Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 AbbVie
  • 13.1.1 AbbVie Company Details
  • 13.1.2 AbbVie Business Overview and Its Total Revenue
  • 13.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
  • 13.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2015-2020))
  • 13.1.5 AbbVie Recent Development
• 13.2 Johnson & Johnson
  • 13.2.1 Johnson & Johnson Company Details
  • 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
  • 13.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.2.5 Johnson & Johnson Recent Development
• 13.3 Amgen Inc
  • 13.3.1 Amgen Inc Company Details
  • 13.3.2 Amgen Inc Business Overview and Its Total Revenue
  • 13.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
  • 13.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.3.5 Amgen Inc Recent Development
• 13.4 AstraZeneca PLC
  • 13.4.1 AstraZeneca PLC Company Details
  • 13.4.2 AstraZeneca PLC Business Overview and Its Total Revenue
  • 13.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
  • 13.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.4.5 AstraZeneca PLC Recent Development
• 13.5 Pfizer, Inc
  • 13.5.1 Pfizer, Inc Company Details
  • 13.5.2 Pfizer, Inc Business Overview and Its Total Revenue
  • 13.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
  • 13.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.5.5 Pfizer, Inc Recent Development
• 13.6 Novartis
  • 13.6.1 Novartis Company Details
  • 13.6.2 Novartis Business Overview and Its Total Revenue
  • 13.6.3 Novartis Anti-inflammatory Therapeutics Introduction
  • 13.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.6.5 Novartis Recent Development
• 13.7 Roche
  • 13.7.1 Roche Company Details
  • 13.7.2 Roche Business Overview and Its Total Revenue
  • 13.7.3 Roche Anti-inflammatory Therapeutics Introduction
  • 13.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.7.5 Roche Recent Development
• 13.8 Merck
  • 13.8.1 Merck Company Details
  • 13.8.2 Merck Business Overview and Its Total Revenue
  • 13.8.3 Merck Anti-inflammatory Therapeutics Introduction
  • 13.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.8.5 Merck Recent Development
• 13.9 Sanofi
  • 13.9.1 Sanofi Company Details
  • 13.9.2 Sanofi Business Overview and Its Total Revenue
  • 13.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
  • 13.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.9.5 Sanofi Recent Development
• 13.10 GlaxoSmithKline
  • 13.10.1 GlaxoSmithKline Company Details
  • 13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 13.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
  • 13.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 13.10.5 GlaxoSmithKline Recent Development
• 13.11 Sun Pharmaceutical Industries Ltd
  • 10.11.1 Sun Pharmaceutical Industries Ltd Company Details
  • 10.11.2 Sun Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
  • 10.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
  • 10.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
• 13.12 TEVA
  • 10.12.1 TEVA Company Details
  • 10.12.2 TEVA Business Overview and Its Total Revenue
  • 10.12.3 TEVA Anti-inflammatory Therapeutics Introduction
  • 10.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
  • 10.12.5 TEVA Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer